News March 4, 2026
BURLINGTON, Mass. and JERUSALEM, March 4, 2026 — BrainsWay Ltd. (NASDAQ & TASE: BWAY) unveiled...
News February 17, 2026
Change in ADS ratio aimed at simplifying comparisons to ordinary shares traded on the Tel Aviv Stock...
News January 12, 2026
BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home...
Events, News November 21, 2025
Deep TMS™ becomes first and only TMS device cleared in treatment of patients ages 15 to 86 suffering...
Events June 12 - June 14, 2025
BrainsWay is attending the CTMSS conference June 13th through June 14th, in San Diego, CA. We invite...
Events May 9 - May 14, 2025
BrainsWay is attending the International Neuromodulation Society conference from May 9th through May...
In the media November 24, 2025
Key takeaways: BrainsWay Deep TMS is cleared for use by adolescents and adults with major depressive...
In the media October 1, 2025
Serenity Mental Health Centers, one of the leading providers of Deep TMS treatment nationwide, commits...
In the media September 26, 2025
Coordinating transcranial magnetic stimulation (TMS) with ketamine therapy shows promising potential...
